Free Trial

Repligen (RGEN) Earnings Date, Estimates & Call Transcripts

Repligen logo
$127.59 +1.40 (+1.11%)
As of 05/20/2025 04:00 PM Eastern

Repligen Earnings Summary

Repligen issued Q1 2025 earnings on April 29, 2025, reporting an EPS of $0.39, which topped the consensus estimate of $0.35 by $0.04. Quarterly revenue rose 10.4% year-over-year to $169.17 million, above analysts' expectations of $163.65 million. With a trailing EPS of -$0.45, Repligen's earnings are expected to grow 37.21% next year, from $1.72 to $2.36 per share.

Upcoming Q2
Earnings Date
Jul. 29Before Market OpensEstimated
Consensus EPS
(Apr. 29)
$0.35
Actual EPS
(Apr. 29)
$0.39 Beat By $0.04
Actual Revenue
(Apr. 29)
$169.17M

Q1 2025 Earnings Resources

RGEN Upcoming Earnings

Repligen's next earnings date is estimated for Tuesday, July 29, 2025, based on past reporting schedules.

Get Repligen Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Repligen and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

RGEN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RGEN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Repligen Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20253$0.32$0.44$0.37
Q2 20253$0.39$0.47$0.42
Q3 20253$0.39$0.46$0.42
Q4 20253$0.46$0.59$0.52
FY 2025 12 $1.56 $1.96 $1.73
Q1 20262$0.49$0.65$0.57
Q2 20261$0.57$0.57$0.57
Q3 20261$0.58$0.58$0.58
Q4 20261$0.64$0.64$0.64

Repligen Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/29/2025
(Estimated)
--------
4/29/2025Q1 2025$0.35$0.39+$0.04$0.10$163.65M$169.17M
2/20/2025Q4 2024$0.41$0.44+$0.03-$0.60$167.58M$167.55M
11/12/2024Q3 2024$0.34$0.43+$0.09$0.87$153.34M$154.87M
7/30/2024Q2 2024$0.33$0.33-$0.60$154.11M$154.07M
5/1/2024Q1 2024$0.29$0.28 -$0.01$0.52$150.06M$151.31M
2/21/2024Q4 2023$0.33$0.33-$1.12$155.38M$155.74M
10/31/2023Q3 2023$0.14$0.23+$0.09$0.14$140.68M$141.20M
8/2/2023Q2 2023$0.49$0.53+$0.04$0.71$165.93M$159.20M

Repligen Earnings - Frequently Asked Questions

Repligen has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 29th, 2025 based off last year's report dates. Learn more on RGEN's earnings history.

Repligen updated its FY 2025 earnings guidance on Tuesday, April, 29th. The company provided earnings per share (EPS) guidance of 1.630-1.720 for the period, compared to the consensus earnings per share estimate of 1.710. The company issued revenue guidance of $695.0 million-$720.0 million, compared to the consensus revenue estimate of $700.8 million.

In the previous quarter, Repligen (NASDAQ:RGEN) reported $0.39 earnings per share (EPS) to beat the analysts' consensus estimate of $0.35 by $0.04. Learn more on analysts' earnings estimate vs. RGEN's actual earnings.

The conference call for Repligen's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Repligen's latest earnings report can be read online.
Read Transcript

Repligen (NASDAQ:RGEN) has a recorded annual revenue of $650.43 million.

Repligen (NASDAQ:RGEN) has a recorded net income of $35.60 million. RGEN has generated -$0.45 earnings per share over the last four quarters.

Repligen (NASDAQ:RGEN) has a forward price-to-earnings ratio of 74.18. The price/earnings-to-growth ratio is 4.54.

Repligen's earnings are expected to grow from $1.72 per share to $2.36 per share in the next year, which is a 37.21% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:RGEN) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners